India has initiated an integrated response against COVID-19 pandemic: Harsh Vardhan
India is hosting clinical trials for all the major vaccines, and about 20 vaccines remain in different phases of development, states the Union Minister.
From development of native vaccines to unique point-of-care diagnostics, India has started an integrated response to overcome the unprecedented COVID-19 pandemic, Union Minister Harsh Vardhan said on Saturday.
Speaking at the 8th BRICS STI Ministerial Satisfying hung on Friday, Mr. Vardhan said India is also hosting scientific trials for all the significant vaccines, and about 20 vaccines are in various phases of advancement.
2 of them are in the most innovative stage of development. Covaxin developed through ICMR-Bharat Biotech collaboration and Covishield from the Serum Institute of India. Both are in Phase-III medical trial stage, he added.
” India has started an integrated response to conquer this unprecedented COVID-19 pandemic.”
” From the development of indigenous vaccines, unique point-of-care diagnostics and healing formulations based upon traditional knowledge, to establishing research resources and using services, Indian R&D entities, both public and personal, are working relentlessly to establish effective interventions for combating the pandemic,” Mr. Vardhan, who holds the charge of Health Ministry in addition to the Science and Innovation Ministry, said.
Valery Falkov, Russian Minister of Science and Higher Education, Marcos Pontes, Brazilian Minister of Science, Innovation and Innovation, Huang Wei, First Vice Minister of Science and Innovation, China, Bonginkosi Emmanuel Nzimande, South African Minister of Greater Education, Science and Technology and several other dignitaries from member countries got involved in the meeting.
Mr. Vardhan said more than 100 start-ups have actually developed ingenious items for COVID-19
He stated the federal government has revealed a $120 million grant for COVID-19 vaccine research. This is being attended to Covid Suraksha (Objective for protection from Covid) and is to be utilized simply for research study and development in this field, he said.
” The grant does not cover the real expense of the vaccine and its distribution expenditures, which will be made individually as and when the vaccine is available,” he said.
Mr. Vardhan stated India is likewise hosting scientific trials for all the major vaccine competitors. Serum Institute of India, the world’s largest vaccine maker, is carrying out trials for the vaccine developed by Oxford University, he said.
” One of our pharma giants, Dr Reddy’s Laboratories, will disperse the Russian vaccine in India after conducting final-stage human trials and getting regulatory approval,” the Minister stated.
Mr.Vardhan stated India will actively contribute in application of BRICS STI Calendar of Activities 2020-21 and assistance extension of clinical activities under BRICS MOU on Science, Technology and Development.
The BRICS member leaders applauded India for the ‘SERB– POWER’ (Promoting Opportunities For Ladies in Exploratory Research) scheme released last month, the Department of Science and Technology stated.
” We have recently introduced a plan ‘SERB– POWER’ to encourage and support becoming well as distinguished females researchers to undertake R&D activities in areas of science and engineering. We might consider networking BRICS ladies scientists through a devoted platform and mechanism,” he added.
CLICK HERE TO LEARN MORE
( the headline, this story has actually not been released by Important India News personnel and is released from a syndicated feed.).